The estimated Net Worth of Kirtley C. Stephenson is at least $318 mil dollars as of 19 August 2015. Mr. Stephenson owns over 9,700 units of SeaSpine Corp stock worth over $92,538 and over the last 9 years he sold SPNE stock worth over $0. In addition, he makes $225,000 as Independent Non-Executive Chairman of the Board at SeaSpine Corp.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Stephenson SPNE stock SEC Form 4 insiders trading
Kirtley has made over 1 trades of the SeaSpine Corp stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 9,700 units of SPNE stock worth $149,283 on 19 August 2015.
The largest trade he's ever made was buying 9,700 units of SeaSpine Corp stock on 19 August 2015 worth over $149,283. On average, Kirtley trades about 539 units every 0 days since 2015. As of 19 August 2015 he still owns at least 9,700 units of SeaSpine Corp stock.
You can see the complete history of Mr. Stephenson stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Kirtley Stephenson biography
Kirtley C. Stephenson serves as Independent Non-Executive Chairman of the Board of the Company. Mr. Stephenson was President of the U.S. Spine business of Integra LifeSciences Holdings Corporation, where he was responsible for sales, marketing, research and development and other related functions. Mr. Stephenson served as President and CEO of SeaSpine, Inc. from 2002 until it was sold to Integra in May 2011. Mr. Stephenson has over 28 years of experience in the medical device industry with 17 years of experience in the spine market. Prior to cofounding SeaSpine, Inc. in 2002, Mr. Stephenson was Vice President of Sales & Marketing at Alphatec. Mr. Stephenson received a B.A. in Business Administration from the University of Cincinnati and an M.B.A. degree from Xavier University. and president of Integra’s U.S. spine business.
What is the salary of Kirtley Stephenson?
As the Independent Non-Executive Chairman of the Board of SeaSpine Corp, the total compensation of Kirtley Stephenson at SeaSpine Corp is $225,000. There are 11 executives at SeaSpine Corp getting paid more, with Keith Valentine having the highest compensation of $1,840,570.
How old is Kirtley Stephenson?
Kirtley Stephenson is 61, he's been the Independent Non-Executive Chairman of the Board of SeaSpine Corp since 2015. There are 1 older and 20 younger executives at SeaSpine Corp. The oldest executive at SeaSpine Holdings Corp is Keith Bradley, 75, who is the Independent Director.
What's Kirtley Stephenson's mailing address?
Kirtley's mailing address filed with the SEC is C/O SEASPINE HOLDINGS CORPORATION, 5770 ARMADA DR, CARLSBAD, CA, 92008.
Insiders trading at SeaSpine Corp
Over the last 9 years, insiders at SeaSpine Corp have traded over $2,659,931 worth of SeaSpine Corp stock and bought 297,805 units worth $3,591,897 . The most active insiders traders include Stuart Essig, Richard E Caruso y Keith Valentine. On average, SeaSpine Corp executives and independent directors trade stock every 39 days with the average trade being worth of $151,762. The most recent stock trade was executed by John J. Winge on 1 January 2023, trading 4,868 units of SPNE stock currently worth $46,441.
What does SeaSpine Corp do?
SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal implants solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine's orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine's spinal implants portfolio consists of an extensive line of products to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures. Expertise in both orthobiologic sciences and spinal implants product development allows SeaSpine to offer its surgeon customers a differentiated portfolio and a complete solution to meet their fusion requirements. SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide.
What does SeaSpine Corp's logo look like?
Complete history of Mr. Stephenson stock trades at SeaSpine Corp
SeaSpine Corp executives and stock owners
SeaSpine Corp executives and other stock owners filed with the SEC include:
-
Keith Valentine,
President, Chief Executive Officer, Director -
Keith C. Valentine,
Pres, CEO & Director -
John Bostjancic,
Chief Financial Officer, Senior Vice President, Treasurer -
Tyler Lipschultz,
Senior Vice President, Orthobiologics and Business Development -
Patrick Keran,
Vice President, General Counsel, Secretary -
John Winge,
Vice President of Sales -
John J. Bostjancic,
Sr. VP, CFO & Treasurer -
Patrick L. Keran,
Sr. VP, Gen. Counsel & Sec. -
Dr. Beau Standish P.Eng., Ph.D.,
Pres of Enabling Technologies -
Kimberly Commins-Tzoumakas,
Independent Director -
Renee Gaeta,
Independent Director -
Kirtley Stephenson,
Independent Non-Executive Chairman of the Board -
Stuart Essig,
Lead Independent Director -
Michael Fekete,
Independent Director -
Keith Bradley,
Independent Director -
John Henneman,
Independent Director -
Dennis Cirino,
Senior Vice President, Global Spinal Systems -
Hollis Winkler,
Sr. VP of HR -
Patrick L. Keran J.D.,
Sr. VP, Gen. Counsel & Sec. -
Dr. Frank Vizesi,
Chief Scientific Officer -
Shaeffer Bannigan,
Sr. Director of Product Devel. -
Paul Benny,
VP, Corp. Controller, Assistant Treasurer & Assistant Sec. -
Dr. Beau Standish Ph.D.,
Pres of Enabling Technologies -
Dennis L. Cirino,
Sr. VP of Global Spinal Systems -
Tyler P. Lipschultz,
Sr. VP of Orthobiologics & Bus. Devel. -
John J. Winge,
VP of Sales -
Carrie Mendivil,
Head of Investor Relations -
James M Sullivan,
Director -
Cheryl R Blanchard,
Director -
Brian D. Baker,
VP, Global Operations -
Richard E Caruso,
10% owner -
Shweta Maniar,
Director -
Life Sciences Corp Integra ...,
-
Beau Standish,
President, Enabling Tech -
Angela Steinway,
Director